• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

Covid-19: FG to buy Oxford/AstraZeneca vaccine

Adeyemi Adebayo by Adeyemi Adebayo
January 25, 2021
in Socio Economic, Spotlight
AstraZeneca set to buy Alexion for $39 billion
Share on FacebookShare on TwitterShare on Linkedin

The FG has stated that it will buy Oxford/AstraZeneca Covid-19 vaccine for Nigerians, given the availability of facilities needed for its storage.

This is according to the Executive Director/Chief Executive Officer of the National Primary Health Care Development Agency (NPHCDA), Dr. Faisal Shuaib, as reported by The Nation.

Speaking during a television interview, Dr Shuaib asserted: “The AstraZeneca type Oxford vaccines are the ones that we want to invest in because we already have the infrastructure across the country to be able to store the vaccines.”

RelatedStories

Global health coalition invests over $250 million in Lassa fever vaccine research  

Lassa fever cases decline in Nigeria, fatality rate remains high at 18.7% – NCDC

March 17, 2025
Cholera: 2,323 casualties so far in 69,925 cases- NCDC

NCDC confirms Lassa fever death in Nigerian doctor after UK trip, raises surveillance alert

March 10, 2025

READ: Combined Vaccine Manufacturing capacity to hit 6.8 billion doses in 2021

He noted the Oxford/AstraZeneca vaccine can be stored in a facility with temperature +2 to +8 degree Celsius for a long period without it losing potency.

The decision may mean that Pfizer/BioNTech’s vaccine will not be considered since it appears the country lacks the capacity to keep the drug at the required temperature level for a long time.

READ: COVID-19: WHO advises vaccine firms and wealthy nations to stop bilateral deals

The NPHCDA added that the National Agency for Food and Drug Administration and Control (NAFDAC) would assess and certify the vaccine to ensure that it is safe.

Noting that: “For us, this is the paramount consideration and no vaccine will be administered to Nigerians until and unless NAFDAC goes through the process of making sure that all of the documentation is right and it is contextualised within the Nigerian environment.”

READ: Covid-19: EU says it will force vaccine companies to respect supply contract

What they are saying

Dr Shuaib noted that:

“In Nigeria, as I speak, almost every single political ward has one freezer that can keep these vaccines at the right temperature.

“Only about 700 political wards do not have this type of equipment, and we are hopeful that if we keep installing them at the pace that we want to, hopefully by the end of this year, we will be able to finish installing, so that in every single political ward, we have the right equipment to be able to store our routine immunisation vaccines, including the COVID-19 vaccines at + 2 to +8 degree Celsius.

READ: Pfizer/BioNTech Covid-19 vaccine appears effective against key mutation – Study reveals

“At this point, we have information from the COVAX facility that Nigeria will be getting up to 100,000 doses of the Pfizer vaccines in February. But ahead of those shipments, we have already made sure that the ultra-chain equipment that is required to keep these vaccines in temperatures of -70 degrees Celsius are available in-country.

“We are also working with the sub-national levels to make sure that when these vaccines are transported to the states and council areas, we will be able to make sure that the transportation takes place in a way that ensures that the vaccines remain and retain their potency.”

READ: Covid-19: FG publishes list of suspended passports for refusing post-arrival Covid-19 test

What you should know

  • Nairametrics reported on 2oth January that the FG favours and will acquire vaccines that need less cooling. The report had it that the FG is in talks with Russia and India to procure vaccines that are less dependent on cooling facilities.
  • Oxford’s AstraZeneca vaccine is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus – although it cannot cause illness.
  • When the vaccine is injected into a patient, it prompts the immune system to start making antibodies and primes it to attack any coronavirus infection.
  • Unlike Pfizer’s vaccine – which has to be kept at an extremely cold temperature (-70 degree Celsius), the Oxford vaccine can be stored in a normal fridge – making it easier to distribute.
  • The vaccine was approved for use by UK’s medicines regulator – the MHRA on December 30, last year. The MHRA approved the use of two full doses, which was found to be 62 per cent effective.

According to Nairametrics Covid-19 tracker, as of Saturday 24th January 2021

  • The total number of cases stood at 121,566.
  • The total number of death stood at 1,497.
  • The total number of tests conducted stood at 1,258,534.

Follow us for Breaking News and Market Intelligence.
Tags: NCDCNigeria Centre for Disease Control
Adeyemi Adebayo

Adeyemi Adebayo

Adeyemi holds a PhD in Accounting Sciences. He has worked in the Educational Sector and as an Independent Consultant.

Related Posts

Global health coalition invests over $250 million in Lassa fever vaccine research  
Health

Lassa fever cases decline in Nigeria, fatality rate remains high at 18.7% – NCDC

March 17, 2025
Cholera: 2,323 casualties so far in 69,925 cases- NCDC
Health

NCDC confirms Lassa fever death in Nigerian doctor after UK trip, raises surveillance alert

March 10, 2025
NCDC records surge in Lassa fever cases in 2023
Health

NCDC reports 80 deaths from lassa fever as fatality rate rises to 19.4% across 11 states 

February 23, 2025
NCDC records surge in Lassa fever cases in 2023
Health

Diphtheria crisis: NCDC reports over 41,000 suspected cases across all states  

February 8, 2025
Nigeria on alert after Ebola outbreak confirmed in Uganda – NCDC DG 
Health

Nigeria on alert after Ebola outbreak confirmed in Uganda – NCDC DG 

February 3, 2025
NCDC records surge in Lassa fever cases in 2023
Health

NCDC confirms 54 Lassa fever cases, 18.5% deaths rate in early 2025 

January 19, 2025
Next Post
Covid-19: EU says it will force vaccine companies to respect supply contract

Covid-19: EU says it will force vaccine companies to respect supply contract

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

first bank








DUNS

Recent News

  • DMO allots N4.27 billion in FGN Savings Bonds for July 2025 
  • Meet the TECNO SPARK 40: A Marvel, an embodiment of power, performance, technology, and style 
  • Nigeria’s capital importation fell sharply under Buhari, FPI peaked and crashed, FDI persistently weak despite reforms 

Follow us on social media:

Recent News

FGN Bonds, bond, DMO set to auction N150 billion in FGN Bonds to investors , FGN Bond for February 2020 oversubscribed by investors, DMO suspends April 2020 FGN savings bond offer

DMO allots N4.27 billion in FGN Savings Bonds for July 2025 

July 17, 2025
Meet the TECNO SPARK 40: A Marvel, an embodiment of power, performance, technology, and style 

Meet the TECNO SPARK 40: A Marvel, an embodiment of power, performance, technology, and style 

July 17, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics